| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5597341 | The Annals of Thoracic Surgery | 2017 | 7 Pages |
Abstract
O3 therapy significantly delayed the onset of CR regulating the expression of genes involved in its pathogenesis. No known immunosuppressive therapy has been capable of achieving similar results. From a translational point of view, O3 therapy could become a new adjuvant treatment for CR in patients undergoing LT.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Norberto MD, PhD, Pedro PhD, Bernardino MD, PhD, MarÃa D. MD, PhD, Keila MVD, Adil MD, Khalid MD, Nagib A. MD, PhD, Lamberto MD, PhD, Wissam MD, Leandro MD, PhD, Ricardo PhD, Chyun-Yin J. MD, Faiz Y. MD, FACS,